Evidence map›Paper›PMID 33704819›Full record

ArticleEquine veterinary journal2022

Active equine parvovirus-hepatitis infection is most frequently detected in Austrian horses of advanced age.

Marcha Badenhorst, Phebe de Heus, Angelika Auer, Birthe Tegtmeyer, Alexander Stang, Katharina Dimmel, Alexander Tichy, Jakub Kubacki, Claudia Bachofen, Eike Steinmann and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Equine veterinary journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Prevalence of equine parvovirus-hepatitis in healthy broodmares in Ontario, Canada.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2023
    Article
  6. Article
  7. Nasal transmission of equine parvovirus hepatitis.Journal of veterinary internal medicine · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Equine parvovirus hepatitis.Equine veterinary journal · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Marcha BadenhorstDepartment for Companion Animals and Horses, University Equine Clinic - Internal Medicine, University of Veterinary Medicine Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-5732-1281
Phebe de HeusDepartment for Companion Animals and Horses, University Equine Clinic - Internal Medicine, University of Veterinary Medicine Vienna, Vienna, Austria.
Angelika AuerInstitute of Virology, University of Veterinary Medicine Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-4790-9823
Birthe TegtmeyerInstitute for Experimental Virology, TWINCORE Centre for Experimental and Clinical Infection Research, Medical School Hannover (MHH) - Helmholtz Centre for Infection Research (HZI), Hannover, Germany.ORCID https://orcid.org/0000-0003-3875-0707
Alexander StangDepartment of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Katharina DimmelInstitute of Virology, University of Veterinary Medicine Vienna, Vienna, Austria.
Alexander TichyDepartment of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, Austria.
Jakub KubackiVetSuisse Faculty, Institute of Virology, University of Zurich, Zurich, Switzerland.
Claudia BachofenVetSuisse Faculty, Institute of Virology, University of Zurich, Zurich, Switzerland.
Eike SteinmannDepartment of Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Jessika M V CavalleriDepartment for Companion Animals and Horses, University Equine Clinic - Internal Medicine, University of Veterinary Medicine Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-8575-7402
University of Veterinary Medicine Vienna · ATUniversity Hospitals of the Ruhr-University of Bochum · DEUniversity of Zurich · CHHelmholtz Centre for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEquine parvovirus-hepatitis (EqPV-H) research is in its infancy. Information regarding prevalence, geographical distribution, genetic diversity, pathogenesis and risk factors enhances understanding of this potentially fatal infection.

objectivesDetermining the prevalence of EqPV-H in Austrian equids. Investigating factors increasing probability of infection, liver-associated biochemistry parameters, concurrent equine hepacivirus (EqHV) infection and phylogenetic analysis of Austrian EqPV-H variants. STUDY

designCross-sectional study.

methodsSera from 259 horses and 13 donkeys in Austria were analysed for anti-EqPV-H VP1-specific antibodies by luciferase immunoprecipitation system (LIPS) and EqPV-H DNA by nested polymerase chain reaction (PCR). Associations between infection status, sex and age were described. Glutamate dehydrogenase (GLDH), gamma-glutamyl transferase (GGT), bile acids and albumin concentrations were compared between horses with active infection and PCR-negative horses. PCR targeting partial EqPV-H NS1 was performed and phylogenetic analysis of Austrian EqPV-H variants was conducted. Complete coding sequences (CDS) of four Austrian variants were determined by next-generation sequencing (NGS) and compared with published sequences.

resultsHorses' EqPV-H seroprevalence was 30.1% and DNA prevalence was 8.9%. One horse was co-infected with EqHV. Significantly, higher probability of active EqPV-H infection was identified in 16- to 31-year-old horses, compared with 1- to 8-year-old horses (P = 0.002; OR = 8.19; 95% CI = 1.79 to 37.50) and 9- to 15-year-old horses (P = 0.03; OR = 2.96; 95% CI = 1.08 to 8.17). Liver-associated plasma parameters were not significantly different between horses with active infection and controls. Austrian EqPV-H variants revealed high similarity to sequences worldwide. No evidence of EqPV-H was detected in donkeys. MAIN LIMITATIONS: Equids' inclusion depended upon owner consent. There was only one sampling point per animal and the sample of donkeys was small.

conclusionsEqPV-H antibodies and DNA are frequently detected in Austrian horses, without associated hepatitis in horses with active infection. The risk of active EqPV-H infection increases with increasing age. Phylogenetic evidence supports close relation of EqPV-H variants globally, including Austrian variants.

Indexed as

HepatitisHepatitis, Viral, AnimalHorse DiseasesParvoviridae InfectionsParvovirusAnimalsAustriaCross-Sectional StudiesEquidaeHorsesPhylogenySeroepidemiologic Studieshorseliverluciferase immunoprecipitation systemnested polymerase chain reactionnext-generation sequencingungulate copiparvovirus 6

Identifiers

PMID33704819
PMCPMC9292856
OpenAlexW3134670996

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.